Pleomorphic xanthoastrocytoma

From Libre Pathology
Revision as of 06:45, 10 December 2014 by Michael (talk | contribs) (+infobx)
Jump to navigation Jump to search

Pleomorphic xanthoastrocytoma, abbreviated PXA, is neuropathology tumour classically associated with seizures.

Pleomorphic xanthoastrocytoma
Diagnosis in short

Pleomorphic xanthoastrocytoma.

LM marked nuclear atypia, eosinophilic granular bodies - very common, inflammation (chronic), no necrosis
Site brain - typical temporal lobe

Clinical history seizure, children & young adults

General

Features:

  • Classically in the temporal lobe in children and young adults.
  • Associated with seizures.
  • Moderately aggressive (WHO Grade II).[1]

Gross

  • Temporal lobe - classic.
  • Usually assoc. with the leptomeninges,[1] i.e. superficial.

Microscopic

Features:[2]

  • Marked nuclear atypia.
  • Eosinophilic granular bodies - very common.[1]
  • Inflammation (chronic).

Notes:

Images

www:

Stains

Image:

IHC

  • GFAP +ve.
  • CD68 +ve.

See also

References

  1. 1.0 1.1 1.2 Fouladi, M.; Jenkins, J.; Burger, P.; Langston, J.; Merchant, T.; Heideman, R.; Thompson, S.; Sanford, A. et al. (Jul 2001). "Pleomorphic xanthoastrocytoma: favorable outcome after complete surgical resection.". Neuro Oncol 3 (3): 184-92. PMID 11465399.
  2. Kumar, Vinay; Abbas, Abul K.; Fausto, Nelson; Aster, Jon (2009). Robbins and Cotran pathologic basis of disease (8th ed.). Elsevier Saunders. pp. 1333. ISBN 978-1416031215.
  3. 3.0 3.1 Dias-Santagata, D.; Lam, Q.; Vernovsky, K.; Vena, N.; Lennerz, JK.; Borger, DR.; Batchelor, TT.; Ligon, KL. et al. (2011). "BRAF V600E mutations are common in pleomorphic xanthoastrocytoma: diagnostic and therapeutic implications.". PLoS One 6 (3): e17948. doi:10.1371/journal.pone.0017948. PMID 21479234.